In the present study the phosphorylation level of UCHL1 was found significantly increased in the N2aSW cells treated with selenate, suggesting that selenate can affect the activity of UPS via modulating the phosphorylation level of UCHL1, thus has an impact on AD formation and progress. Here, UCHL1 is linked to Alzheimer disease.